ML20199A229: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
Line 18: Line 18:


=Text=
=Text=
{{#Wiki_filter:-      -    -
{{#Wiki_filter:-
      ' ' Mr. Robert W. Sharkey. Manager             November 6, 1997 l
' ' Mr. Robert W. Sharkey. Manager November 6, 1997 lLf
Lf
-Regulatory Compliance Combustion Engineering. Inc.
              -Regulatory Compliance Combustion Engineering. Inc.
3300 State Road P.
3300 State Road P.
              ; Hematite.- M0 63047
; Hematite.- M0 63047
                $UBJECT:     AMENDMENT REQUEST FOR UNRESTRICTED RELEASE OF HYDROFLUORIC ACID (TAC NO. L30995)
$UBJECT:
AMENDMENT REQUEST FOR UNRESTRICTED RELEASE OF HYDROFLUORIC ACID (TAC NO. L30995)


==Dear Mr. Sharkey:==
==Dear Mr. Sharkey:==
 
This refers to your application dated August 12. 1997. requesting-an amendment to Materials License SNM 33 to authorize release of hydrofluoric acid for unrestricted use.
,              This refers to your application dated August 12. 1997. requesting-an amendment to Materials License SNM 33 to authorize release of hydrofluoric acid for unrestricted use.
Our review of your application has identified additional information that is needed before final action can be taken on your request. The additional information, specified in the enclosure, should be provided within 30 days of the date'of this letter.
Our review of your application has identified additional information that is needed before final action can be taken on your request. The additional information, specified in the enclosure, should be provided within 30 days of the date'of this letter. Please reference the above TAC No, in future correspondence related to this request.
Please reference the above TAC No, in future correspondence related to this request.
If you have any questions regarding this matter, please contact me at (301) 415-8155.
If you have any questions regarding this matter, please contact me at (301) 415-8155.
Sincerely.
Sincerely.
Sean Soong Licensing Section 2                         ,
Sean Soong Licensing Section 2 Licensing Branch 7
Licensing Branch                           7 Division of Fuel Cycle Safety       N and Safeguards. NMSS
Division of Fuel Cycle Safety N
                                                                                                  )
and Safeguards. NMSS
I Docket     70-36 License    SNM-33                      b."$ k!E @ijJ$ Q,p1.1                   i Enclosurei As-stated Distribution: w/ encl.   (Control No. 700S) [ PARTIAL)
)
Docket 70-36             PUBl.IC             .NRC File Center   FCSS R/F Region III               FCLB R/F             TReidinger. RIII NMSS R/F
I Docket 70-36 b."$ k!E @ijJ$ Q,p1.1 i
[c:\chotoo\ hematite \hf. rail 0FC.-   FCLB     E     FCLB     F       FCLB     h     FCLB A/
License SNM-33 Enclosurei As-stated Distribution: w/ encl.
NAME   Schotoo-efd - SSoong fy           PSD.a- 3d       MATJ)Why 11/[;'/97 DATE   11/ (o /97       11//, -/97                       11/ lo /97
(Control No. 700S) [ PARTIAL)
          .9711170109 971106T                                               ,
Docket 70-36 PUBl.IC
.NRC File Center FCSS R/F Region III FCLB R/F TReidinger. RIII NMSS R/F
[c:\\chotoo\\ hematite \\hf. rail 0FC.-
FCLB E
FCLB F
FCLB h
FCLB A/
NAME Schotoo-ef - SSoong fy PSD.a-3d MATJ)Why d
DATE 11/ (o
/97 11//, -/97 11/[;'/97 11/ lo /97
.9711170109 971106T


L-.         ~,
L-.
4
~,
            .              Request for Additional Information Application Dated August 12, 1997                     i Combustion Engineering, Inc.
4 Request for Additional Information Application Dated August 12, 1997 Combustion Engineering, Inc.
Docket 70 36
Docket 70 36 1.
: 1. Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example. in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for this possibility, considering not only the original buyer but possible end uses of the material.
Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example. in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for this possibility, considering not only the original buyer but possible end uses of the material.
: 2. Commit to representative sampling of the hold tank before release of carb batch of HF.
2.
: 3. You indicated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank. What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is sufficient.
Commit to representative sampling of the hold tank before release of carb batch of HF.
: 4. Indicate the total volume of HF per year Vnich is expected to be transferred from the site for unrestricted use.
3.
: 5. Correct the dose unit in the third column of Table 2 of your August 12.
You indicated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank.
What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is sufficient.
4.
Indicate the total volume of HF per year Vnich is expected to be transferred from the site for unrestricted use.
5.
Correct the dose unit in the third column of Table 2 of your August 12.
1997. submittal.
1997. submittal.
: 6. Provide the basis for the internal dose estimates used to calculate he total effective dose equivalent presented on page 9 of your August 12.
6.
1997, submittal. The internal doses cited are lnconsistent with the calculations presented on pages 6 and 7 of your submittal ENCLOSURE
Provide the basis for the internal dose estimates used to calculate he total effective dose equivalent presented on page 9 of your August 12.
1997, submittal.
The internal doses cited are lnconsistent with the calculations presented on pages 6 and 7 of your submittal ENCLOSURE


      -        _ . _ _ . - . . . _ _ _ _ .                  ~   _      . . _ . _ . . _ _ _ . _ _ . . _ _ _ _                    _ _ .
~
y                                                                                                                                       '
y T.
November 6, 1997 T.
* LMr LRobertW;Shnkey, Manager November 6, 1997
* LMr LRobertW;Shnkey, Manager
+
    +       Regulatory Compliance 1 Combustion Engineering; Inc.           _
Regulatory Compliance 1 Combustion Engineering; Inc.
3300 State Road P                                                                                                               '
3300 State Road P Aematite,'MO63047-
Aematite,'MO63047-


==SUBJECT:==
==SUBJECT:==
-                'AMLNDMENT;REQUESTFORUNRESTRICTEDRELEASEOFHYDROFLOORICIACID
'AMLNDMENT;REQUESTFORUNRESTRICTEDRELEASEOFHYDROFLOORICIACID
                                      .(TAC NO. L30995)                                                                                     ,
.(TAC NO. L30995) t p
t p
L
L


==Dear Mr. Sharkey:==
==Dear Mr. Sharkey:==
 
This refers to your application dated August 12, 1997, requesting an amendment to Materials License SNM-33 to authorize release of hydrofluoric acid for unrestricted use, Our review of your application has identified additional information that'is needed before final action can be taken on your request. Th'e additional information, specified in the enclosure, shouhl be provided within 30 days of
This refers to your application dated August 12, 1997, requesting an amendment to Materials License SNM-33 to authorize release of hydrofluoric acid for unrestricted use,                                                                                                               ,
-the date of this letter.
Our review of your application has identified additional information that'is needed before final action can be taken on your request. Th'e additional information, specified in the enclosure, shouhl be provided within 30 days of                                                   .
Please reference-the above TAC No, in future correspondence related to this request.
            -the date of this letter. Please reference-the above TAC No, in future correspondence related to this request.
If'you have any questions regarding this matter, please contact me at (301)
.            If'you have any questions regarding this matter, please contact me at (301)
'415-8155.
          '415-8155.
Sincerely, Sean Soong Licensing Section 2 Licensing Branch Division of Fuel Cycle Safety e
Sincerely, Sean Soong Licensing Section 2
and Safeguards -NMSS Docket 70-36 License SNM-33
  -                                                                Licensing Branch e                                                                  Division of Fuel Cycle Safety and Safeguards -NMSS Docket                 70-36 License               SNM-33


==Enclosure:==
==Enclosure:==
As stated Distribution: -w/ encl.                 (Control No; 7005)-[ PARTIAL]
As stated Distribution: -w/ encl.
Docket 70-36:                           PUBLICL                 NRC' File Center                     FCSS R/F
(Control No; 7005)-[ PARTIAL]
          -Region III                               FCLB R/F_               TReidinger. RIII NMSS R/F-
Docket 70-36:
[c:\chotoo\ hematite \hf.rai)'
PUBLICL NRC' File Center FCSS R/F
0FC           FCLR             E- FCLB     g         FCLB                   h               FCLB A)
-Region III FCLB R/F_
NAME'         SchotooJegC- SSoong-9;                   PShea - M                             M%y DATE'         11/ (,       /97     11/fi   /97   _
TReidinger. RIII NMSS R/F-
11/ [             '/97                 11/ lo /97 NMN                                       __.                  _          __              .-                      _  .._ _    _ _ .
[c:\\chotoo\\ hematite \\hf.rai)'
0FC FCLR E-FCLB g
FCLB h
FCLB A)
NAME' SchotooJegC-SSoong-9; PShea - M M%y DATE' 11/ (,
/97 11/fi
/97 11/ [
'/97 11/ lo /97 NMN


  ?   =
?
4
=
                                                                                                                                            ~
4 P.equest for Additional Information
P.equest for Additional Information Application Dated August 12, 1997 Combustion Engineering, Inc.                                             >
~
Docket 70 36
Application Dated August 12, 1997 Combustion Engineering, Inc.
: 1. Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example, in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for tnis possibility, considering not only the original buyer but possible end uses of the materic1.
Docket 70 36 1.
: 2. Commit to representetive sampling of the hold tank before , clease of ertl batch of HF.
Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example, in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for tnis possibility, considering not only the original buyer but possible end uses of the materic1.
: 3. You inalcated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank. What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is suf ficient.
2.
: 4. Indicate the total volume of HF per year which is expected to be trensierred from the site for unrestricted use.
Commit to representetive sampling of the hold tank before, clease of ertl batch of HF.
: 5. Correct the dose unit in the third column of Table 2 of your August 12.
3.
You inalcated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank.
What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is suf ficient.
4.
Indicate the total volume of HF per year which is expected to be trensierred from the site for unrestricted use.
5.
Correct the dose unit in the third column of Table 2 of your August 12.
1997, submittal.
6.
Provide the basis for the internal dose estimates used to calculate the total effective dose equivalent presented on page 9 of your August 12.
1997, submittal.
1997, submittal.
: 6. Provide the basis for the internal dose estimates used to calculate the total effective dose equivalent presented on page 9 of your August 12.
The internal doses cited are inconsistent with the calculations presented on pages 6 and 7 of your submittal.
1997, submittal. The internal doses cited are inconsistent with the calculations presented on pages 6 and 7 of your submittal.
9 ENCLOSURE L
9 ENCLOSURE L     -
_ _ _ _ _ _ - _ _ _ _ _ _ _ _}}
_ - _ _ _ _ _ _ _ _ _ - _ _ _ _ _ _ _ _}}

Latest revision as of 08:53, 10 December 2024

Forwards RAI Re Amend Application,Dtd 970812,requesting Authorization for Release of Hydrofluoric Acid for Unrestricted Use
ML20199A229
Person / Time
Site: 07000036
Issue date: 11/06/1997
From: Soong S
NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
To: Sharkey R
ABB COMBUSTION ENGINEERING NUCLEAR FUEL (FORMERLY
References
TAC-L30995, NUDOCS 9711170109
Download: ML20199A229 (2)


Text

-

' ' Mr. Robert W. Sharkey. Manager November 6, 1997 lLf

-Regulatory Compliance Combustion Engineering. Inc.

3300 State Road P.

Hematite.- M0 63047

$UBJECT:

AMENDMENT REQUEST FOR UNRESTRICTED RELEASE OF HYDROFLUORIC ACID (TAC NO. L30995)

Dear Mr. Sharkey:

This refers to your application dated August 12. 1997. requesting-an amendment to Materials License SNM 33 to authorize release of hydrofluoric acid for unrestricted use.

Our review of your application has identified additional information that is needed before final action can be taken on your request. The additional information, specified in the enclosure, should be provided within 30 days of the date'of this letter.

Please reference the above TAC No, in future correspondence related to this request.

If you have any questions regarding this matter, please contact me at (301) 415-8155.

Sincerely.

Sean Soong Licensing Section 2 Licensing Branch 7

Division of Fuel Cycle Safety N

and Safeguards. NMSS

)

I Docket 70-36 b."$ k!E @ijJ$ Q,p1.1 i

License SNM-33 Enclosurei As-stated Distribution: w/ encl.

(Control No. 700S) [ PARTIAL)

Docket 70-36 PUBl.IC

.NRC File Center FCSS R/F Region III FCLB R/F TReidinger. RIII NMSS R/F

[c:\\chotoo\\ hematite \\hf. rail 0FC.-

FCLB E

FCLB F

FCLB h

FCLB A/

NAME Schotoo-ef - SSoong fy PSD.a-3d MATJ)Why d

DATE 11/ (o

/97 11//, -/97 11/[;'/97 11/ lo /97

.9711170109 971106T

L-.

~,

4 Request for Additional Information Application Dated August 12, 1997 Combustion Engineering, Inc.

Docket 70 36 1.

Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example. in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for this possibility, considering not only the original buyer but possible end uses of the material.

2.

Commit to representative sampling of the hold tank before release of carb batch of HF.

3.

You indicated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank.

What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is sufficient.

4.

Indicate the total volume of HF per year Vnich is expected to be transferred from the site for unrestricted use.

5.

Correct the dose unit in the third column of Table 2 of your August 12.

1997. submittal.

6.

Provide the basis for the internal dose estimates used to calculate he total effective dose equivalent presented on page 9 of your August 12.

1997, submittal.

The internal doses cited are lnconsistent with the calculations presented on pages 6 and 7 of your submittal ENCLOSURE

~

y T.

  • LMr LRobertW;Shnkey, Manager November 6, 1997

+

Regulatory Compliance 1 Combustion Engineering; Inc.

3300 State Road P Aematite,'MO63047-

SUBJECT:

'AMLNDMENT;REQUESTFORUNRESTRICTEDRELEASEOFHYDROFLOORICIACID

.(TAC NO. L30995) t p

L

Dear Mr. Sharkey:

This refers to your application dated August 12, 1997, requesting an amendment to Materials License SNM-33 to authorize release of hydrofluoric acid for unrestricted use, Our review of your application has identified additional information that'is needed before final action can be taken on your request. Th'e additional information, specified in the enclosure, shouhl be provided within 30 days of

-the date of this letter.

Please reference-the above TAC No, in future correspondence related to this request.

If'you have any questions regarding this matter, please contact me at (301)

'415-8155.

Sincerely, Sean Soong Licensing Section 2 Licensing Branch Division of Fuel Cycle Safety e

and Safeguards -NMSS Docket 70-36 License SNM-33

Enclosure:

As stated Distribution: -w/ encl.

(Control No; 7005)-[ PARTIAL]

Docket 70-36:

PUBLICL NRC' File Center FCSS R/F

-Region III FCLB R/F_

TReidinger. RIII NMSS R/F-

[c:\\chotoo\\ hematite \\hf.rai)'

0FC FCLR E-FCLB g

FCLB h

FCLB A)

NAME' SchotooJegC-SSoong-9; PShea - M M%y DATE' 11/ (,

/97 11/fi

/97 11/ [

'/97 11/ lo /97 NMN

?

=

4 P.equest for Additional Information

~

Application Dated August 12, 1997 Combustion Engineering, Inc.

Docket 70 36 1.

Is there a possibility that the uranium released in the hydrofluoric acid (HF) may be reconcentrated (for example, in a waste treatment or metal recovery operation after use of the HF)? Provide a conservative dose assessment for tnis possibility, considering not only the original buyer but possible end uses of the materic1.

2.

Commit to representetive sampling of the hold tank before, clease of ertl batch of HF.

3.

You inalcated in your August 12. 1997, submittal that a diked pad will be constructed for the HF holding tank.

What volume of HF will the diked area be capable of containing in the event of a leak? Justify why this volume is suf ficient.

4.

Indicate the total volume of HF per year which is expected to be trensierred from the site for unrestricted use.

5.

Correct the dose unit in the third column of Table 2 of your August 12.

1997, submittal.

6.

Provide the basis for the internal dose estimates used to calculate the total effective dose equivalent presented on page 9 of your August 12.

1997, submittal.

The internal doses cited are inconsistent with the calculations presented on pages 6 and 7 of your submittal.

9 ENCLOSURE L

_ _ _ _ _ _ - _ _ _ _ _ _ _ _